Biological Computers: Rising Prevalence of Communicable Diseases Drives The Growth of The Global Market

Pune, India, December, 2022 /MRFR Press Release/- Market Research Future has a cooked research report on the global biological computers market. The global biological computers market is growing continuously and expected to grow at a CAGR of 22.6% from 2022 to 2030.

Market Highlights

Biological computers are systems developed form basic components such as software, hardware, input and output. DNA and RNA are the basis of biological systems used as software for constructing the biological systems.

Prevalence of cancer such as lung cancer, mouth cancer, and bone cancer is on the rise across the globe, especially in the developing countries. The market is driven by the increasing prevalence of respiratory diseases in rural areas for developing countries. In addition, increasing research and development activities in the field of oncology, and technological advancements made to identify the causes and risk factors for chronic diseases have added fuel to the global biological computers market growth. Rising awareness about gene chip and other biological systems that can be used for cell transformation with the help of information technology also drives the market growth.

The global biological computers market is projected to reach USD 5,480 Million by 2030 at 22.6% CAGR during the forecast period 2022-2030.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Biological computers market research report–Global forecast till 2030.”

Major Players in Biological Computers Market:

Some of the major players in the global biological computers market are Microsoft (U.S.), IBM (U.S.), Thermofisher Scientific (U.S.), Illumina, Inc. (U.S.), IndieBio (U.S.), Emulate Inc. (U.S.), and others. Key players in manufacturing DNA or gene chips are Sequenom Inc., Merck KGaA (U.S.), Macrogen Corp (Republic of Korea), Bioneer Corporation (Republic of Korea), Biometrix Technology Inc (U.S.), Wafergen Biosystems Inc. (U.S.), and Eurofins Genomics India Pvt Ltd. (India).

Regional Analysis

In America, the market is expected to grow at the fastest rate and holds the first position in the market owing to the rising prevalence of cancer in the U.S., and increasing demand for new cancer diagnostic and treatment services. Concentration of key players in the U.S. also influences the market growth in the Americas. Furthermore, increasing healthcare expenditure also drives the market. In North America, healthcare spending has shown positive growth from last few years. According to Centers for Medicare & Medicaid Services, national health spending is projected to grow at an average rate of 5.6 % per year for 2016-25, and 4.7 % per year on a per capita basis. Additionally, in 2013, pharmaceutical spending in the EOCD countries reached around USD 800 billion, which is about 20% of total health spending.

In Europe, there is an increasing demand for healthcare IT solutions and extensive research and development activities is being carried out by clinical research and academic institutes for cancer treatment. According to Cancer Research UK, in 2014, 356,860 new cases of cancer were reported, including 579 cases of bone cancer. 

In Asia Pacific, increasing prevalence of chronic disease such as kidney disease, obesity, diabetes and other along with rising geriatric population has attributed to an increasing demand for technologically advanced medical devices such as gene chips, and advanced therapies. Increasing government initiatives in research for rare diseases and various types of cancer has also influenced the growth of the market.

In the Middle East & Africa, Middle East captures the largest market share for biological medicines owing to the availability of better healthcare infrastructure and wide scope for research. In Africa, the demand for new medical devices and accessories has also driven the growth of the market. Healthcare infrastructure in various African countries is improving for the last few years, thus contributing to the market growth.

Explore In-depth Details: Biological computers Market Research Report

Segmentation

The global biological computers market is segmented on the basis of component, application, and end user.

On the basis of the component, market is segmented into hardware, software, input, and output.

On the basis of the application, the market is segmented into oncology, molecular genetics, nano biotechnology, and others.

On the basis of the end user, the market is segmented into pharmaceutical & biotechnology companies, research centers, healthcare it companies, hospital & clinics, and others.